Bluejay Diagnostics, Inc. (NASDAQ:BJDX) Short Interest Update

by · The Cerbat Gem

Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Get Free Report) saw a significant decrease in short interest during the month of September. As of September 30th, there was short interest totalling 39,900 shares, a decrease of 59.2% from the September 15th total of 97,700 shares. Approximately 0.2% of the shares of the company are sold short. Based on an average daily volume of 2,170,000 shares, the days-to-cover ratio is currently 0.0 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Bluejay Diagnostics stock. CVI Holdings LLC purchased a new stake in shares of Bluejay Diagnostics, Inc. (NASDAQ:BJDX – Free Report) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 66,165 shares of the company’s stock, valued at approximately $46,000. CVI Holdings LLC owned about 19.69% of Bluejay Diagnostics as of its most recent SEC filing. 18.47% of the stock is owned by institutional investors and hedge funds.

Bluejay Diagnostics Stock Performance

Shares of Bluejay Diagnostics stock remained flat at $0.12 on Friday. 2,064,405 shares of the stock were exchanged, compared to its average volume of 819,269. The firm’s 50 day simple moving average is $0.20 and its 200 day simple moving average is $2.21. Bluejay Diagnostics has a 12 month low of $0.11 and a 12 month high of $38.96. The stock has a market cap of $38,908.80, a price-to-earnings ratio of 0.00 and a beta of 0.70.

Bluejay Diagnostics (NASDAQ:BJDX – Get Free Report) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($5.12) earnings per share (EPS) for the quarter.

Bluejay Diagnostics Company Profile

(Get Free Report)

Bluejay Diagnostics, Inc, a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components.

Featured Stories